Role of MLH1/MSH2 expression in tumor phenotype and invasion in stages 0 and 1 sporadic colorectal adenocarcinomas

被引:0
|
作者
Blanes, A.
Jimenez, J. J.
Diaz-Cano, S. J.
机构
[1] Univ Malaga, Sch Med, E-29071 Malaga, Spain
[2] Kings Coll Hosp, London, England
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
515
引用
收藏
页码:113A / 114A
页数:2
相关论文
共 50 条
  • [41] Prevalence of MLH1 and MSH2 germline mutations in Sardinian patients with colorectal carcinoma
    Colombino, M
    Budroni, M
    Cossu, A
    Satta, MP
    Baldinu, P
    Palomba, G
    Casula, M
    Sini, MC
    Camboni, MG
    Palmieri, G
    ANNALS OF ONCOLOGY, 2005, 16 : 284 - 284
  • [42] Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer
    Baert-Desurmont, Stephanie
    Buisine, Marie-Pierre
    Bessenay, Emilie
    Frerot, Stephanie
    Lovecchio, Tonio
    Martin, Cosette
    Olschwang, Sylviane
    Wang, Qing
    Frebourg, Thierry
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) : 383 - 386
  • [43] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105
  • [44] Prediction of MLH1 and MSH2 mutations in Lynch syndrome
    Balmana, Judith
    Stockwell, David H.
    Steyerberg, Ewout W.
    Stoffel, Elena M.
    Deffenbaugh, Amie M.
    Reid, Julia E.
    Ward, Brian
    Scholl, Thomas
    Hendrickson, Brant
    Tazelaar, John
    Burbidge, Lynn Anne
    Syngal, Sapna
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (12): : 1469 - 1478
  • [45] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [46] Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer
    Casey, G
    Lindor, NM
    Papadopoulos, N
    Thibodeau, SN
    Moskow, J
    Steelman, S
    Buzin, CH
    Sommer, SS
    Collins, CE
    Butz, M
    Aronson, M
    Gallinger, S
    Barker, MA
    Young, JP
    Jass, JR
    Hopper, JL
    Diep, A
    Bapat, B
    Salem, M
    Seminara, D
    Haile, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07): : 799 - 809
  • [47] MSH2 and MLH1 immunodetection and the prognosis of colon cancer
    Perrin, J
    Monges, G
    Parriaux, D
    Noguchi, T
    Giovannini, MH
    Giovannini, M
    Delpero, JR
    Birnbaum, D
    Monges, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (05) : 891 - 895
  • [48] Risks of cancer for MLH1 and MSH2 mutation carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel
    Thibodeau, Stephen N.
    Casey, Graham
    Lindor, Noralane M.
    Gallinger, Steve
    Le Marchand, Loic
    Haile, Robert
    Newcomb, Polly
    Hopper, John L.
    Jenkins, Mark A.
    GENETIC EPIDEMIOLOGY, 2009, 33 (08) : 811 - 811
  • [49] Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer
    Rey, JM
    Noruzinia, M
    Brouillet, JP
    Sarda, P
    Maudelonde, T
    Pujol, P
    CANCER GENETICS AND CYTOGENETICS, 2004, 155 (02) : 149 - 151
  • [50] DNA repair proteins MLH1, MSH2, MSH6, and MGMT in 495 gastric and esophageal adenocarcinomas
    Fukuda, E.
    Begnami, M. D.
    Fregnani, J. H.
    Silva, E. M.
    Soares, F. A.
    Coudry, R. A.
    Soares, F. A.
    LABORATORY INVESTIGATION, 2008, 88 : 119A - 119A